200 related articles for article (PubMed ID: 20532912)
1. Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.
Wright JM; Dunn LA; Kazimierczuk Z; Burgess AG; Krauer KG; Upcroft P; Upcroft JA
Parasitol Res; 2010 Sep; 107(4):847-53. PubMed ID: 20532912
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
Adagu IS; Nolder D; Warhurst DC; Rossignol JF
J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
[TBL] [Abstract][Full Text] [Related]
3. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
Narcisi EM; Secor WE
Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
[TBL] [Abstract][Full Text] [Related]
4. Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women.
Mabaso N; Abbai N
Parasitol Res; 2021 Jun; 120(6):2233-2241. PubMed ID: 34002261
[TBL] [Abstract][Full Text] [Related]
5. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
[TBL] [Abstract][Full Text] [Related]
6. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
Meri T; Jokiranta TS; Suhonen L; Meri S
J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
[TBL] [Abstract][Full Text] [Related]
7. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
Hager WD
Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
Schwebke JR; Barrientes FJ
Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
[TBL] [Abstract][Full Text] [Related]
11. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Mammen-Tobin A; Wilson JD
Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
[TBL] [Abstract][Full Text] [Related]
12. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
13. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
[TBL] [Abstract][Full Text] [Related]
14. Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen.
Rasoloson D; Tomková E; Cammack R; Kulda J; Tachezy J
Parasitology; 2001 Jul; 123(Pt 1):45-56. PubMed ID: 11467782
[TBL] [Abstract][Full Text] [Related]
15. 'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole-resistant Trichomonas vaginalis strains.
Malagoli M; Rossi T; Baggio A; Zandomeneghi G; Zanca A; Casolari C; Castelli M
Pharmacol Res; 2002 Nov; 46(5):469-72. PubMed ID: 12419652
[TBL] [Abstract][Full Text] [Related]
16. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus.
Bouma MJ; Snowdon D; Fairlamb AH; Ackers JP
J Antimicrob Chemother; 1998 Dec; 42(6):817-20. PubMed ID: 10052908
[TBL] [Abstract][Full Text] [Related]
17. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
[TBL] [Abstract][Full Text] [Related]
18. Treatment of metronidazole-resistant Trichomonas vaginalis.
Goldman LM; Upcroft JA; Workowski K; Rapkin A
Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205
[TBL] [Abstract][Full Text] [Related]
19. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
Nix DE; Tyrrell R; Müller M
Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
